Viewing Study NCT06816966


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-05 @ 5:59 PM
Study NCT ID: NCT06816966
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-02-10
First Post: 2025-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Sponsor:
Organization: